New study to uncover hidden brain effects of Cutting-Edge cancer treatments
NCT ID NCT07558057
First seen May 02, 2026 · Last updated May 25, 2026 · Updated 2 times
Summary
This study looks at whether newer immunotherapies for blood cancers, like CAR-T cells and bispecific antibodies, cause lasting problems with memory, attention, and thinking. Researchers will test 225 patients in Denmark using standard cognitive tests and questionnaires. The goal is to better understand these side effects so doctors can support patients and develop ways to prevent or treat them.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aarhus University Hospital
Aarhus, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.